...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM?

....accessing the 2020 IPOs especially in biotech the Market Cap assigned by the backing entitiy averages about $300 Million....however once trading that MC can explode! I assume DMcC puts a value on Zen in the Billions as I type,,,,my point is the sale price might just increase due to market assessment....

An IPO would result in further substantial dilution. MC could explode?  ZHCLF tells me otherwise. Value in the billions?  Isn't that what I hear about RVX?  Google "agoracom rvx billions" and count the hits.  My point is that the sale price might just decrease due to market assessment. No thanks.

Share
New Message
Please login to post a reply